Monika Sharma

Employment

• Yale University Instructor
  2024 - Present
• Brigham and Women's Hospital Postdoctoral fellow
  2019 - 2023
• National Brain Research Centre Junior Research Fellow
  2012 - 2014
• CSIR Institute of Genomics & Integrative Biology Research Trainee
  2010 - 2011

Education

• University of Alberta PhD
  2014 - 2019
• University of Rajasthan Master's
  2009 - 2011
• Sophia Girl's College B.Sc.
  2006 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Impact of a CD36 inhibitor on Porphyromonas gingivalis mediated atherosclerosis
  Archives of Oral Biology 2021 DOI: 10.1016/j.archoralbio.2021.105129
  +Save
• Adrenergic Receptors as Pharmacological Targets for Neuroinflammation and Neurodegeneration in Parkinson’s Disease
  Neuroprotection 2019 DOI: 10.5772/intechopen.81343
  +Save
• Mechanism underlying β2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells.
  Journal of neuroimmunology 2019 DOI: 10.1016/j.jneuroim.2019.03.017
  +Save
• β-arrestin2 regulates the anti-inflammatory effects of Salmeterol in lipopolysaccharide-stimulated BV2 cells.
  Journal of neuroimmunology 2018 DOI: 10.1016/j.jneuroim.2018.10.001
  +Save
• Reactive Oxygen Species Mediate Therapeutic Ultrasound-Induced, Mitogen-Activated Protein Kinase Activation in C28/I2 Chondrocytes.
  Ultrasound in medicine & biology 2018 DOI: 10.1016/j.ultrasmedbio.2018.05.025
  +Save
• Salmeterol, a Long-Acting β2-Adrenergic Receptor Agonist, Inhibits Macrophage Activation by Lipopolysaccharide From Porphyromonas gingivalis.
  Journal of periodontology 2017 DOI: 10.1902/jop.2017.160464
  +Save
• Inflammation: Role in Parkinson's Disease and Target for Therapy
  Challenges in Parkinson's Disease 2016 DOI: 10.5772/63164
  +Save
• Astrocytes mediate HIV-1 Tat-induced neuronal damage via ligand-gated ion channel P2X7R.
  Journal of neurochemistry 2015 DOI: 10.1111/jnc.12953
  +Save